| Product name |
Excedrin Migraine Caplets, Excedrin Migraine Geltabs, Excedrin Extra Strength Caplets, Excedrin PM Headache Caplets, and Excedrin Tension Headache Caplets |
| Description |
This recall involves 50, 80, 100, 125, 200, 250 and 300-count bottles of Excedrin Migraine Caplets, Excedrin Migraine Geltabs, Excedrin Extra Strength Caplets, Excedrin PM Headache Caplets, and Excedrin Tension Headache Caplets. The bottles are plastic with a child-resistant closure. For a full list of the recalled products, visit www.excedrin.com/products/discontinued. |
| Problem |
Some of the bottles containing the over-the-counter drug can have a hole in the bottom. If there is a hole, children could access and swallow the contents, posing a risk of poisoning. These products contain the substances aspirin and acetaminophen which must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA). |
| Distribution |
Pharmacies, department stores, grocery stores, and hypermarkets nationwide and online for between $7 and $18. |
| Company |
GSK Consumer Relations 800-468-7746; web site www.excedrin.com |
| Dates sold |
March 2018 through September 2020 |
| Date posted |
12/23/2020 |
| Additional information |
For additional information, visit the U.S. Consumer Product Safety Commission's news release at https://www.cpsc.gov/Recalls/2021/GSK-Consumer-Health-Recalls-Five-Excedrin-Brands-Due-to-Failure-to-Meet-Child-Resistant-Packaging-Requirement-Risk-of-Poisoning |
| Image |
|
|
|
